DB:FJ3

Stock Analysis Report

NOT FOR DISTRIBUTION
Header cover image

Executive Summary

Fujimori Kogyo Co., Ltd. provides packaging materials, medical/pharmaceutical packaging materials, and materials for functional field in Japan. More Details


Snowflake Analysis

Flawless balance sheet, undervalued and pays a dividend.

Share Price & News

How has Fujimori Kogyo's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: FJ3 has not had significant price volatility in the past 3 months.


Market Performance


7 Day Return

3.8%

FJ3

1.3%

DE Chemicals

0.2%

DE Market


1 Year Return

20.5%

FJ3

-4.4%

DE Chemicals

6.6%

DE Market

Return vs Industry: FJ3 exceeded the German Chemicals industry which returned -4.4% over the past year.

Return vs Market: FJ3 exceeded the German Market which returned 6.6% over the past year.


Shareholder returns

FJ3IndustryMarket
7 Day3.8%1.3%0.2%
30 Day11.6%6.1%2.1%
90 Day8.6%11.0%5.6%
1 Year23.3%20.5%0.06%-4.4%9.1%6.6%
3 Year28.5%20.9%-18.5%-27.5%6.8%-1.8%
5 Year71.9%54.0%12.7%-6.2%38.9%20.1%

Price Volatility Vs. Market

How volatile is Fujimori Kogyo's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is Fujimori Kogyo undervalued compared to its fair value and its price relative to the market?

23.5%

Undervalued compared to fair value


Share Price vs. Fair Value

Below Fair Value: FJ3 (€32.8) is trading below our estimate of fair value (€42.85)

Significantly Below Fair Value: FJ3 is trading below fair value by more than 20%.


Price To Earnings Ratio

PE vs Industry: FJ3 is good value based on its PE Ratio (13.7x) compared to the DE Chemicals industry average (26.3x).

PE vs Market: FJ3 is good value based on its PE Ratio (13.7x) compared to the German market (22.3x).


Price to Earnings Growth Ratio

PEG Ratio: FJ3 is poor value based on its PEG Ratio (2x)


Price to Book Ratio

PB vs Industry: FJ3 is good value based on its PB Ratio (1.2x) compared to the DE Chemicals industry average (1.4x).


Next Steps

Future Growth

How is Fujimori Kogyo forecast to perform in the next 1 to 3 years based on estimates from 1 analyst?

6.7%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: FJ3's forecast earnings growth (6.7% per year) is above the savings rate (0.2%).

Earnings vs Market: FJ3's earnings (6.7% per year) are forecast to grow slower than the German market (27.7% per year).

High Growth Earnings: FJ3's earnings are forecast to grow, but not significantly.

Revenue vs Market: FJ3's revenue (3.8% per year) is forecast to grow slower than the German market (6% per year).

High Growth Revenue: FJ3's revenue (3.8% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: FJ3's Return on Equity is forecast to be low in 3 years time (8.6%).


Next Steps

Past Performance

How has Fujimori Kogyo performed over the past 5 years?

4.9%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: FJ3 has high quality earnings.

Growing Profit Margin: FJ3's current net profit margins (5%) are lower than last year (5.2%).


Past Earnings Growth Analysis

Earnings Trend: FJ3's earnings have grown by 4.9% per year over the past 5 years.

Accelerating Growth: FJ3's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: FJ3 had negative earnings growth (-1.2%) over the past year, making it difficult to compare to the Chemicals industry average (-11.9%).


Return on Equity

High ROE: FJ3's Return on Equity (8.8%) is considered low.


Next Steps

Financial Health

How is Fujimori Kogyo's financial position?


Financial Position Analysis

Short Term Liabilities: FJ3's short term assets (¥66.1B) exceed its short term liabilities (¥31.5B).

Long Term Liabilities: FJ3's short term assets (¥66.1B) exceed its long term liabilities (¥6.1B).


Debt to Equity History and Analysis

Debt Level: FJ3's debt to equity ratio (2%) is considered satisfactory.

Reducing Debt: FJ3's debt to equity ratio has reduced from 2.5% to 2% over the past 5 years.

Debt Coverage: FJ3's debt is well covered by operating cash flow (545.8%).

Interest Coverage: FJ3 earns more interest than it pays, so coverage of interest payments is not a concern.


Balance Sheet


Next Steps

Dividend

What is Fujimori Kogyo current dividend yield, its reliability and sustainability?

1.68%

Current Dividend Yield


Upcoming Dividend Payment


Dividend Yield vs Market

Notable Dividend: FJ3's dividend (1.68%) is higher than the bottom 25% of dividend payers in the German market (1.17%).

High Dividend: FJ3's dividend (1.68%) is low compared to the top 25% of dividend payers in the German market (3.61%).


Stability and Growth of Payments

Stable Dividend: FJ3's dividends per share have been stable in the past 10 years.

Growing Dividend: FJ3's dividend payments have increased over the past 10 years.


Current Payout to Shareholders

Dividend Coverage: With its low payout ratio (22.9%), FJ3's dividend payments are well covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: Insufficient data to determine if a dividend will be paid in 3 years and that it will be covered by earnings.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

4.6yrs

Average management tenure


CEO

Eishi Fuyama (66 yo)

6.92yrs

Tenure

Eishi Fuyama serves as President of Fujimori Kogyo Co., Ltd since October 2013 and served as General Manager of Life Science Business Division since April 2009 respectively and served as its Senior Managin ...


Leadership Team

NamePositionTenureCompensationOwnership
Eishi Fuyama
President & Representative Director6.92yrsno data0.037%
¥ 235.0k
Akijiro Yoshino
Managing Exec. Officer12.25yrsno data0.037%
¥ 235.0k
Kimihiko Shiomi
Managing Executive Officer & Director8.25yrsno data0.026%
¥ 167.9k
Tetsuro Oe
Managing Executive Officer & Director3.25yrsno data0.0053%
¥ 33.5k
Hiroshi Komori
Executive Officerno datano datano data
Hiroshi Saga
Senior Executive Officer6.25yrsno data0.016%
¥ 100.7k
Atsushi Takematsu
GM of Functional Containers Division - Head Office of Life Science Business & Executive Officer4.92yrsno datano data
Michihiko Sato
Executive Officer & GM of Adhesive Materials Solution Division4.25yrsno datano data
Kazuma Eguchi
Exec. Officer2.25yrsno datano data
Takahiro Imura
Executive Officer & GM of Functional Materials Division & Electronics Materials Departmentno datano datano data
Taku Shimoda
Executive Officer & GM of Advanced Medical Business Promotion & Business Planning Departmentno datano datano data
Toyoaki Suzuki
Executive Officer & General Manager of R & D Centerno datano datano data

4.6yrs

Average Tenure

61yo

Average Age

Experienced Management: FJ3's management team is considered experienced (4.6 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Eishi Fuyama
President & Representative Director6.92yrsno data0.037%
¥ 235.0k
Akijiro Yoshino
Managing Exec. Officer12.25yrsno data0.037%
¥ 235.0k
Kimihiko Shiomi
Managing Executive Officer & Director8.25yrsno data0.026%
¥ 167.9k
Tetsuro Oe
Managing Executive Officer & Director3.25yrsno data0.0053%
¥ 33.5k
Hiroshi Saga
Senior Executive Officer6.25yrsno data0.016%
¥ 100.7k
Akihiko Fujimori
Chairman of the Board6.92yrsno data2.43%
¥ 15.5m
Yukihiko Fujimori
Director32.25yrsno data2.75%
¥ 17.6m
Nobuhiko Fujimori
Vice Chairman6.25yrsno data2.77%
¥ 17.7m
Manabu Sakai
Director2.25yrsno datano data
Eizo Kobayashi
External Director4.25yrsno datano data

6.6yrs

Average Tenure

66yo

Average Age

Experienced Board: FJ3's board of directors are considered experienced (6.6 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Fujimori Kogyo Co., Ltd.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Fujimori Kogyo Co., Ltd.
  • Ticker: FJ3
  • Exchange: DB
  • Founded: 1914
  • Industry: Commodity Chemicals
  • Sector: Materials
  • Market Cap: JP¥79.364b
  • Listing Market Cap: JP¥639.023m
  • Shares outstanding: 19.03m
  • Website: https://www.zacros.co.jp

Number of Employees


Location

  • Fujimori Kogyo Co., Ltd.
  • Shinjuku First West
  • 10th Floor
  • Tokyo
  • 160-0023
  • Japan

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
7917TSE (The Tokyo Stock Exchange)YesCommon SharesJPJPYDec 1993
FJ3DB (Deutsche Boerse AG)YesCommon SharesDEEURDec 1993

Biography

Fujimori Kogyo Co., Ltd. provides packaging materials, medical/pharmaceutical packaging materials, and materials for functional field in Japan. The company offers optoelectronic products, such as MASTACK T ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2020/09/18 03:40
End of Day Share Price2020/09/17 00:00
Earnings2020/06/30
Annual Earnings2020/03/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.